Plantwatch: the trees that feed on metal
These plants can clean contaminated soils, could they also offer a greener way of collecting much-needed substances?A magnificent tall tree calledPycnandra acuminata grows on the island of New Caledonia in the South Pacific, and it does something strange – when its bark is cutit bleeds a bright blue-green latex that contains up to 25% nickel, a metal highly poisonous to most plants in more than tiny amounts.An estimated 700 plant species have unusually high levels of metal, mostly nickel but not in all cases. The macadamia tree has leaves and sap rich in manganese, although fortunately not in the nut. If such metal-c...
Source: Guardian Unlimited Science - April 21, 2021 Category: Science Authors: Paul Simons Tags: Environment Science Mining Pollution Source Type: news

Superbug killer: New nanotech destroys bacteria and fungal cells
(RMIT University) A new dual bug killer is one of the thinnest antimicrobial coatings to date.The coating works by tearing bacteria and fungal cells apart, offering a smart solution to the twin global health threats of drug-resistant bacterial and fungal infections. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 14, 2021 Category: International Medicine & Public Health Source Type: news

What Are Toxin-Mediated Diseases?
Discussion A poison is a generic term for “a substance with an inherent property that tends to destroy life or impair health.” A toxin is more specific and is “any poison produced by an organism, characterized by antigenicity in certain animals and high molecular weight, and including the bacterial toxins that are the causative agents of tetanus, diphtheria, etc., and such plant and animal toxins as ricin and snake venom.” A toxin does not include those substances that are made synthetically produced. Venom is also a toxin that is used by animals and insects for predation or defense which can cause ...
Source: PediatricEducation.org - April 12, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

NIDCR's Spring 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR & NIH Stand Against Structural Racism NIDCR Director Rena D’Souza, DDS, MS, PhD, said in a statement that there is no place for structural racism in biomedical research, echoing remarks from NIH Director Francis Collins, MD, PhD, in his announcement of a new NIH ...
Source: NIDCR Science News - April 7, 2021 Category: Dentistry Source Type: news

'Germ Hunters' discover rare disease in rural Alberta
(University of Alberta Faculty of Medicine& Dentistry) A rare lung disease that is linked to bats has made Alberta home, according to new research led by scientists at Alberta Precision Laboratories and the University of Alberta. The team of infectious disease experts confirmed that histoplasmosis--a fungal infection transmitted through bat and bird droppings--is now found in Alberta. Their study extends the known range of the disease much farther northwest from its traditional home in the central United States and parts of southern Ontario and Quebec. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 18, 2021 Category: Infectious Diseases Source Type: news

Innovative cancer treatment found to be promising for the control of fungal infections
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) The use of CAR T-cells reprogrammed to 'recognize' Cryptococcus spp. proved effective to combat the infection in vitro and in mice. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 4, 2021 Category: Biology Source Type: news

The battle against hard-to-treat fungal infections
(American Chemical Society) Systemic fungal infections are much rarer than other illnesses, but they are potentially deadly, with limited options for treatment. In fact, fungi are becoming increasingly resistant to the few drugs that are available, and infections are growing more common. A cover story inChemical& Engineering News, the weekly newsmagazine of the American Chemical Society, details how scientists are working to improve our antifungal arsenal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 3, 2021 Category: Infectious Diseases Source Type: news

Fungi in the gut prime immunity against infection
(Weill Cornell Medicine) Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine. Breakdowns in this process can leave people susceptible to deadly fungal infections. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2021 Category: International Medicine & Public Health Source Type: news

New eco-friendly technique protects rice plants against devastating fungal infection
(Tokyo University of Agriculture and Technology) Researchers have developed a new technique to protect rice seeds against fungal infections that can ruin up to half of all rice crops in the world. The biocontrol method, which involves inoculation of flowers with a different fungus that doesn't cause disease and using seeds harvested from the flower to grow crops, is even better at protecting rice plants from diseases than existing fungicide approaches, and could also be used against similar pathogens that affect other staple crops. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 4, 2021 Category: Biology Source Type: news

Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
Human monogenic disorders have revealed the critical contribution of type 17 responses in mucosal fungal surveillance. We unexpectedly found that in certain settings, enhanced type 1 immunity rather than defective type 17 responses can promote mucosal fungal infection susceptibility. Notably, in mice and humans with AIRE deficiency, an autoimmune disease characterized by selective susceptibility to mucosal but not systemic fungal infection, mucosal type 17 responses are intact while type 1 responses are exacerbated. These responses promote aberrant interferon- (IFN-)– and signal transducer and activator of transcript...
Source: ScienceNOW - January 14, 2021 Category: Science Authors: Break, T. J., Oikonomou, V., Dutzan, N., Desai, J. V., Swidergall, M., Freiwald, T., Chauss, D., Harrison, O. J., Alejo, J., Williams, D. W., Pittaluga, S., Lee, C.-C. R., Bouladoux, N., Swamydas, M., Hoffman, K. W., Greenwell-Wild, T., Bruno, V. M., Rose Tags: Immunology, Medicine, Diseases, Online Only r-articles Source Type: news

Antifungal drug improves key cystic fibrosis biomarkers in clinical study
(University of Illinois at Urbana-Champaign, News Bureau) A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study by researchers at the University of Illinois Urbana-Champaign and the University of Iowa found. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 17, 2020 Category: Biology Source Type: news

Research reveals how a fungal infection activates inflammation
(St. Jude Children's Research Hospital) Scientists at St. Jude Children's Research Hospital have shed light on the mechanisms that underlie how Aspergillus fumigatus activates the inflammasome, with implications for therapeutic development. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

Coronavirus Disease 2019 Sepsis: A Nudge Toward Antibiotic Stewardship
COVID-19 is sepsis caused by SARS-CoV-2, a virus for which there is little in the way of antimicrobial therapy. Because it is sepsis, known tenets of sepsis care and organ support must be our guiding principles. Surprisingly, a key lesson that we must take from the war on this viral sepsis is that we must redouble our efforts to be stewards of antimicrobials and ensure that we have adequate means to control bacterial and fungal infection. Moreover, it is critical that high priority be given to randomized controlled trials that are testing drugs to treat SARS-CoV-2 and the ensuing sepsis. As we face subsequent waves of this...
Source: Current Awareness Service for Health (CASH) - November 13, 2020 Category: Consumer Health News Source Type: news

ERC Synergy Project studies drug tolerance in intractable fungal infections
(Charit é - Universit ä tsmedizin Berlin) Over the next six years, research groups at Charit é - Universit ä tsmedizin Berlin and Tel Aviv University will study how invasive fungal pathogens are able to evade treatments and develop tolerance to antifungal drugs. In addition to generating fundamental knowledge of fungal pathogens, this large project aims to provide new insights into fungal cell metabolism. This joint endeavor is supported by a European Research Council ERC Synergy Grant worth approximately € 9.7 million. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 10, 2020 Category: Biology Source Type: news

Oral thrush symptoms: Cracked corners of the mouth may be a sign of the fungal infection
ORAL THRUSH occurs when the fungus, Candida albicans - a normal yeast organism found in your mouth - overgrows. What are the signs of this infection? And how do you treat it? (Source: Daily Express - Health)
Source: Daily Express - Health - October 29, 2020 Category: Consumer Health News Source Type: news

Non-invasive test for diagnosis of invasive fungal infection saves cost
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 30, 2020 Category: Drugs & Pharmacology Source Type: news

SIMPONI ARIA ® (golimumab) Approved by the U.S. Food and Drug Administration for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older
HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This latest FDA approval of SIMPONI ARIA for pediatric use in active pJIA and active PsA not only brings a new option to young patients living with these diseases but also adds to the growing body of evidence for this treatment,” said Mathai Mammen, M.D., Ph.D., Glo...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Source Type: news

Ghana: Oral Treatment of Onychomycosis (Tinea Unguium)
[Ghanaian Times] "I have finger nail infection. I am told it is a fungal infection called Tinea. I have used Griseofulvin in the past. Recently I was put on Itraconazole capsulesby my healthcare provider. My healthcare provider asked me take 200mg twice daily for 1 week, repeat the same for another 1 week the second month and do another 1 week for the third month. The dosing is unusual for me. Will it work?". Yes it will work. It is called Pulse therapy. The alternative is to take 200mg daily for 3 months. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 9, 2020 Category: African Health Source Type: news

Caffeine shot delivers wakeup call on antifungal drug resistance
(University of Edinburgh) The management of fungal infections in plants and humans could be transformed by a breakthrough in understanding how fungi develop resistance to drugs. It was previously thought that only mutations in a fungi's DNA would result in antifungal drug resistance. Current diagnostic techniques rely on sequencing all of a fungi's DNA to find such mutations. Scientists from the University of Edinburgh have discovered that fungi can develop drug resistance without changes to their DNA -- their genetic code. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 9, 2020 Category: International Medicine & Public Health Source Type: news

Cochrane review informs guidelines on managing histoplasmosis in people living with HIV
 In a newsystematic review, an author team from the  Cochrane Infectious Diseases Group explored the evidence regarding managing histoplasmosis in people with HIV. Their review informed the PAHO/WHO guideline development process. The review authors worked with the guideline development group to formulate key questions, including which antifungal drug to start, how long to continue, and when to start antiretroviral medication. They also looked at tuberculosis therapy when people were infected with tuberculosis, HIV, and histoplasmosis.Histoplasmosis is an infection caused by inhaling a fungus called Hist...
Source: Cochrane News and Events - August 11, 2020 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Bacterial, Fungal Coinfection Uncommon in COVID-19 Patients
FRIDAY, July 31, 2020 -- Bacterial and fungal infections are uncommon in hospitalized COVID-19 patients, but coinfection is associated with high mortality and antibiotic use is widespread, according to a study published in the July issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2020 Category: Pharmaceuticals Source Type: news

Isavuconazole for the treatment of invasive fungal infection in solid organ transplant recipients: experience from a referral centre
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - July 1, 2020 Category: Respiratory Medicine Authors: MeganB Source Type: news

Current use of baseline chest CT in haematology patients at high risk for invasive fungal infection
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - June 24, 2020 Category: Respiratory Medicine Authors: MeganB Source Type: news

New family of enzymes reveals the Achilles' heel of fungal pathogens
(Canadian Glycomics Network) Aspergillus fumigatus is a fungal species that can cause serious illnesses in immunocompromised individuals. Infections caused by A. fumigatus are difficult to eliminate because the fungus often aggregates into small communities called " biofilms, " which protect the pathogens from antifungal agents and help the fungus evade the immune system. GlycoNet scientists Drs. Lynne Howell and Don Sheppard recently identified a key enzyme in A. fumigatus that could lead to therapeutics to treat these fungal infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 17, 2020 Category: Infectious Diseases Source Type: news

F2G's Olorofim Receives Both FDA Orphan Drug Designation for Coccidioidomycosis (Valley Fever) and FDA QIDP Designation for Multiple Fungal Infections
Olorofim is currently in Phase 2b development for the treatment of life-threatening fungal infections MANCHESTER, England and VIENNA, Austria, June 10, 2020 -- (Healthcare Sales & Marketing Network) -- F2G Ltd, a UK- and Austria-based biotech developin... Biopharmaceuticals, FDA F2G, orotomides, fungal infection, antifungal, Coccidioidomycosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2020 Category: Pharmaceuticals Source Type: news

Reprogramming of immune system cures child with often-fatal fungal infection
(University of California - Los Angeles Health Sciences) In the June 11 issue of the New England Journal of Medicine, a team of UCLA physicians and scientists describes the first case of immune modulation being used to cure a severe and often fatal fungal infection. The team 'retuned' a 4-year-old's immune system so that it could fight off disseminated coccidioidomycosis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 10, 2020 Category: Infectious Diseases Source Type: news

Cannabis Smoking May Increase Risk for Fungal Infection
THURSDAY, May 14, 2020 -- The likelihood of having a fungal infection was increased in association with cannabis use in 2016, according to a study published online May 13 in Emerging Infectious Diseases, a publication of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 14, 2020 Category: Pharmaceuticals Source Type: news

Ronald Reagan ’s Secret Cancer Cure
There’s no faster way to purify your body of viruses, bacteria and fungi — and at the same time ramp up your immune system — than a 125-year-old “cure” banned by the FDA. I’m talking about ozone therapy — and it’s not just good for cleansing your body. You see, ozone — a special “energized” kind of oxygen — can help heal almost any condition. Despite being banned by the FDA back in the 1940s, after more than 60 years of successful use, ozone therapy has saved millions of lives in countries where it has become a commonplace medical treatment. In count...
Source: Al Sears, MD Natural Remedies - May 12, 2020 Category: Complementary Medicine Authors: Dr.A.Sears Tags: Health Source Type: news

Bacterial and fungal etiology of sepsis in children in the United States: Reconsidering empiric therapy
Conclusion(s): In this nationally representative administrative database, the most common identified pathogen was S. aureus in previously healthy and chronically ill children. In addition, a high proportion of children with sepsis and select chronic diseases had infections with methicillin-resistant S. aureus, fungal infections, Pseudomonas infections, and C. difficile. Clinicians caring for pediatric patients should consider coverage of these organisms when administering empiric antimicrobials for sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 6, 2020 Category: Consumer Health News Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Tanzanian plants found to have potent antimicrobial effects against 7 tested microbes
(Natural News) Despite advances in modern medicine and the availability of a wide range of anti-microbial drugs, the prevalence of bacterial and fungal infections is still high. Statistics show that in 2013, infectious diseases were responsible for the deaths of 3.25 million children worldwide, and bacterial infections accounted for 17.8 percent of the total. In some... (Source: NaturalNews.com)
Source: NaturalNews.com - April 11, 2020 Category: Consumer Health News Source Type: news

GenMark Diagnostics Sees 80% Revenue Boost in First Quarter
COVID-19 has been tough on companies across many different industries but the current pandemic has shined a spotlight on what was previously a quieter corner of medtech: molecular diagnostics. And for the companies in that sector that have stepped up and responded to the crisis with tests to detect SARS-CoV-2 test, the virus that causes COVID-19, those efforts are paying off. On Tuesday, Carlsbad, CA-based GenMark Diagnostics, a provider of automated, multiplex molecular diagnostic testing systems, preannounced first-quarter revenue of about $38.7 million, representing an increase of abo...
Source: MDDI - April 8, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

Flight of the living dead: Fungal infection compels cicadas to go on sexcapades long after their genitals fall off
(Natural News) While it’s true that human zombies still remain in the realm of science fiction, their insect counterparts have been known to science for quite a while. A recent study took a closer look at one of the more macabre causes of this phenomenon: a deadly fungus that turns cicadas into sex zombies as it rots their genitals and... (Source: NaturalNews.com)
Source: NaturalNews.com - April 3, 2020 Category: Consumer Health News Source Type: news

Development of novel oral formulation to treat systemic fungal infections
(Bentham Science Publishers) The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc. (Vancouver BC, Canada) have developed a novel oral formulation of Amphotericin B to treat systemic fungal and parasitic infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 23, 2020 Category: Infectious Diseases Source Type: news

Current epidemiology of invasive fungal infections
Tuesday, March 3, 2020 - 16:20Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 3, 2020 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Tryptophan metabolism in fungal infections
Saturday, February 29, 2020 - 13:03Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 29, 2020 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Study unravels how our immune system deals with fungal and viral infections
(University of Birmingham) The body's immune response to fungal infections changes when a patient is also infected by a virus, according to new research which investigated the two types of infection together for the first time. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 27, 2020 Category: Infectious Diseases Source Type: news

New Player In The Fight Against Resistant Fungal Infections In Phase 3 Trial
Rezofungin hopes to fight increasingly deadly hospital-acquired fungal infections. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 26, 2020 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news

Health Tip: Preventing Athlete's Foot
-- Athlete's foot is a fungal infection that often occurs in people who wear damp socks or tight shoes, says Mayo Clinic. The infection is contagious and is spread by contact with an infected person or contaminated surfaces. To help prevent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 16, 2020 Category: General Medicine Source Type: news

Exploring the epidemiology and diversity of fungal infections in a tertiary renal unit in London, UK
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 15, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

The diagnosis and management of invasive fungal infection in haemato-oncology patients – reviewing departmental guidance
The diagnosis and management of invasive fungal infection in haemato-oncology patients – reviewing departmental guidanceConference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 14, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

Probiotic yeast may offer an effective treatment for drug-resistant fungal infections
(Worcester Polytechnic Institute) Researchers at Worcester Polytechnic Institute (WPI)& the Central Food Technological Research Institute in India are studying the effect of probiotic yeast in preventing fungal infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 10, 2019 Category: Infectious Diseases Source Type: news

Acute Myeloid Leukemia and Antifungal Prophylaxis Era: Compliance of AML Centers, Invasive Fungal Infection (IFI) Classification, IFI Incidence and AML Outcomes from ALFA 2007- 02 Study
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 5, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

Single Arm, Single Centre Prospective Study to Assess the Effect of Therapeutic Drug Monitoring (TDM) Based Dosage Adjustment of Posaconazole on the Incidence of Invasive Fungal Infections (IFIs) in AML Patients on Induction Chemotherapy on Posa prophylax
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 5, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 5, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

More than 35,000 people die every year in the US from antibiotic resistance – and the government is worried about vapes?
(Natural News) A new study by the United States Centers for Disease Control and Prevention (CDC) has revealed that more than 2.8 million people contract antibiotic-resistant bacterial and/or fungal infections every year in America – and of these cases, a shocking 35,000 end in death. On average, one new person living in the U.S. contracts... (Source: NaturalNews.com)
Source: NaturalNews.com - November 27, 2019 Category: Consumer Health News Source Type: news

'Dual login' mechanism found to resist fungal infection in cells
(Indiana University) Indiana University researchers have identified how two immune receptors coordinate closely to trigger a powerful response against fungal invaders, which could help advance research on cancer therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 18, 2019 Category: Cancer & Oncology Source Type: news

North Carolina woman says she was left with fungal infection and bloody fingers after manicure 
WARNING: GRAPHIC CONTENT Bethany, from North Carolina, says she contacted a fungal infection from a nail salon that was using the same dip powder for several customers. (Source: the Mail online | Health)
Source: the Mail online | Health - November 15, 2019 Category: Consumer Health News Source Type: news

How $6 million could help a small Peninsula company spot deadly infections
Inflammatix's tests could quickly determine if the cause of sepsis or fevers is due to a bacterial, viral or fungal infection. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 14, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Chitin-binding proteins override host plant's resistance to fungal infection
(American Phytopathological Society) A recent Molecular Plant-Microbe Interactions article studies chitin-binding proteins from a soilborne fungus (Verticillium nonalfalfae) that causes vascular wilt in plants. This fungus binds a particular protein (VnaChtBP) to chitin in order to abolish the host plant's chitin-triggered burst of reactive oxygen species and shield the fungus from being digested by the plant. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 13, 2019 Category: Biology Source Type: news